Irritable bowel syndrome

References

• Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2(6138): 653–4
   PubMed Web of Science ®Google Scholar
• Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000; 133(2): 136–47
   PubMedGoogle Scholar
• Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991;100(4): 998–1005
   PubMed Web of Science ®Google Scholar
• Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99(2): 409–15
   Google Scholar
• Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38(9): 1569–80
   PubMed Web of Science ®Google Scholar
• Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112(6): 2120–37
   PubMed Web of Science ®Google Scholar
• Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109(6): 1736–41
   PubMed Web of Science ®Google Scholar
• Cann PA, Read NW, Brown C, et al. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983;24(5): 405–11
   PubMed Web of Science ®Google Scholar
• Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987;92(6): 1885–93
   Google Scholar
• Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med 2001;344(24): 1846–50
   PubMed Web of Science ®Google Scholar
• Rothstein RD. Irritable bowel syndrome. Med Clin North Am 2000;84(5): 1247–57
   Google Scholar
• Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990; 98(5 Pt 1): 1187–92
   PubMed Web of Science ®Google Scholar
• Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118(5): 842–8
   PubMed Web of Science ®Google Scholar
• Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997:314(7083): 779–82
   Google Scholar
• Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44(3): 400–6
   Google Scholar
• Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95(12): 3503–6
   PubMed Web of Science ®Google Scholar
• Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95(3): 701–8
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Bosmajian L, Zonderman AB, et al. Symptoms of psychologic distress associated with irritable bowel syndrome: comparison of community and medical clinic samples. Gastroenterology 1988;95(3): 709–14
   PubMed Web of Science ®Google Scholar
• Drossman DA, Talley NJ, Leserman J, et al. Sexual and physical abuse and gastrointestinal illness: review and recommendations. Ann Intern Med 1995;123(10): 782–94
   PubMed Web of Science ®Google Scholar
• Lynn RB, Friedman LS. Irritable bowel syndrome. N Engl J Med 1993; 329(26): 1940–5
   PubMed Web of Science ®Google Scholar
• Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med 1999;107(5A):5–1IS
   Google Scholar
• Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Supp 2):II43–7
   Google Scholar
• Schmulson MW, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999;107(5A):20–6S
   Google Scholar
• Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long- term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122(2): 107–12
   PubMed Web of Science ®Google Scholar
• Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992; 116(12 Pt 1):1009–16
   PubMed Web of Science ®Google Scholar
• Camilleri M. Therapeutic approach to the patient with irritable bowel syndrome. Am J Med 1999;107(5A):27–32S
   Google Scholar
• Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15(3): 355–61
   PubMed Web of Science ®Google Scholar
• Gorard DA, Libby GW, Farthing MJ. Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome. Dig Dis Sci 1995;40(1): 86–95
   Google Scholar
• Clouse RE. Psychotropic medications for the treatment of functional gastrointestinal disorders. Clin Perspect Gastroenterol 1999; 2(Nov/Dec):348–56
   Google Scholar
• Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo- controlled trial. Lancet 2000;355(9209): 1035–40
   PubMed Web of Science ®Google Scholar
• Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000; 118(3): 463–8
   PubMed Web of Science ®Google Scholar
• Zelnorm package insert. East Hanover, NJ: Novartis Pharmaceuticals, July 2002
   Google Scholar
• Cann PA, Read NW, Holdsworth CD, et al. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci 1984; 29(3): 239–47
   PubMed Web of Science ®Google Scholar
• Drossman DA, Creed FH, Olden KW, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45(Suppl 2):II25–30
   PubMedGoogle Scholar
• Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanlysis. Am J Gastroenterol 1998;93(7): 1131–5
   PubMed Web of Science ®Google Scholar